Single-Cell Atlas Reveals How 7 Million Cells Change as Mammals Age
Rockefeller scientists mapped epigenomic aging across 7M cells in 21 tissues, uncovering coordinated, program-like shifts that may unlock new therapies.
Summary
Dr. Junyue Cao's lab at Rockefeller University used a cutting-edge single-cell technique called EasySci-ATAC to map how chromatin accessibility changes in roughly seven million cells across 21 mouse tissues at three different ages. This produced the most comprehensive epigenomic atlas of mammalian aging to date. About a quarter of all cell types shift significantly with age, many changes are coordinated across multiple organs simultaneously, and males and females age differently at the cellular level. The research suggests aging has program-like features, which is encouraging because it implies specific cellular targets exist. Identifying those targets is the essential first step toward designing interventions that slow aging broadly rather than treating one disease at a time.
Detailed Summary
Understanding how individual cells change as an organism ages has long been a bottleneck in longevity science. Without knowing which cells shift, and how, researchers cannot design precise interventions that target aging itself. Dr. Junyue Cao's lab at Rockefeller University has taken a major step toward solving this problem by building what is likely the most detailed epigenomic atlas of mammalian aging ever produced.
Using a technique called EasySci-ATAC, the team profiled chromatin accessibility — essentially, which regions of DNA are open and potentially active — in approximately seven million cells drawn from 21 different mouse tissues. Cells were sampled at three distinct ages, allowing the researchers to track how the cellular landscape evolves over a lifetime. This represents roughly a hundredfold improvement over what commercial single-cell platforms could achieve just a decade ago.
The findings reveal that about 25 percent of all cell types undergo significant changes with age. Critically, many of these changes are coordinated across organs rather than isolated to one tissue, suggesting aging operates through shared, system-wide programs rather than purely local deterioration. The atlas also documents clear sex differences in how aging unfolds at the cellular level, meaning male and female biology may require distinct therapeutic strategies.
Perhaps the most conceptually important insight is that aging appears to have program-like features. Dr. Cao frames this as good news: if aging follows identifiable molecular programs, those programs become targetable. This shifts the research question from 'can we design a drug?' to 'which cellular programs should we target?' — a more tractable problem now that the atlas provides a map.
Key caveats apply. The study was conducted in mice, and translation to human aging biology requires further validation. Chromatin accessibility is one layer of epigenomic regulation; other molecular dimensions remain to be integrated for a complete picture.
Key Findings
- About 25% of cell types shift significantly with age across 21 mouse tissues, identified via 7 million single-cell profiles.
- Age-related cellular changes are often coordinated across multiple organs, suggesting shared systemic aging programs.
- Males and females show distinct aging patterns at the cellular level, implying sex-specific therapeutic targets may be needed.
- Aging appears to have program-like molecular features, making it potentially targetable with precision interventions.
- EasySci-ATAC enables ~100x more cells per experiment than commercial platforms, dramatically improving aging research resolution.
Methodology
This is a research summary and interview based on a peer-reviewed paper published in the journal Science, a top-tier credible source. The study used EasySci-ATAC to generate a large-scale empirical dataset of 7 million cells across 21 tissues in mice. Evidence quality is high for an animal study, though human applicability remains to be established.
Study Limitations
The study was conducted entirely in mice, and epigenomic aging patterns may differ in humans; replication in human tissue is needed. Chromatin accessibility captures only one layer of the epigenome and does not fully represent gene expression, proteomics, or metabolic changes. The article is an interview summary rather than the full primary paper, so methodological details should be verified against the original Science publication.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.